Figure 3.
Correlation between serum miR-9 and disease-free survival. OSCC patients in the low serum miR-9 expression group had a poorer disease-free survival compared with those in the high serum miR-9 expression group (26.53% vs. 54.55%; P=0.004).
Correlation between serum miR-9 and disease-free survival. OSCC patients in the low serum miR-9 expression group had a poorer disease-free survival compared with those in the high serum miR-9 expression group (26.53% vs. 54.55%; P=0.004).